These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12414637)

  • 1. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models.
    Vernejoul F; Faure P; Benali N; Calise D; Tiraby G; Pradayrol L; Susini C; Buscail L
    Cancer Res; 2002 Nov; 62(21):6124-31. PubMed ID: 12414637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer.
    Rochaix P; Delesque N; Estève JP; Saint-Laurent N; Voight JJ; Vaysse N; Susini C; Buscail L
    Hum Gene Ther; 1999 Apr; 10(6):995-1008. PubMed ID: 10223733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells.
    Carrere N; Vernejoul F; Souque A; Asnacios A; Vaysse N; Pradayrol L; Susini C; Buscail L; Cordelier P
    Hum Gene Ther; 2005 Oct; 16(10):1175-93. PubMed ID: 16218779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.
    Benali N; Cordelier P; Calise D; Pages P; Rochaix P; Nagy A; Esteve JP; Pour PM; Schally AV; Vaysse N; Susini C; Buscail L
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9180-5. PubMed ID: 10900262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2.
    Kumar M; Liu ZR; Thapa L; Wang DY; Tian R; Qin RY
    Pancreas; 2004 Aug; 29(2):141-51. PubMed ID: 15257106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer.
    Zhang Z; Huang Y; Newman K; Gu J; Zhang X; Wu H; Zhao M; Xianyu Z; Liu X
    Clin Cancer Res; 2009 Aug; 15(16):5154-60. PubMed ID: 19671855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
    Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
    J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2].
    Manoj K; Liu ZR; Tian R; Qin RY
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):760-5. PubMed ID: 15200918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts.
    Du ZY; Qin RY; Xia W; Tian R; Kumar M
    World J Gastroenterol; 2005 Jan; 11(4):516-20. PubMed ID: 15641137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.
    Ding Y; Wen Y; Spohn B; Wang L; Xia W; Kwong KY; Shao R; Li Z; Hortobagyi GN; Hung MC; Yan DH
    Clin Cancer Res; 2002 Oct; 8(10):3290-7. PubMed ID: 12374701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
    Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
    World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
    Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
    Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster.
    Hara H; Kobayashi A; Yoshida K; Ohashi M; Ohnami S; Uchida E; Higashihara E; Yoshida T; Aoki K
    Cancer Sci; 2007 Mar; 98(3):455-63. PubMed ID: 17233811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor subtype 2 gene therapy inhibits pancreatic cancer in vitro.
    Fisher WE; Wu Y; Amaya F; Berger DH
    J Surg Res; 2002 Jun; 105(1):58-64. PubMed ID: 12069503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways.
    Zhou T; Xiao X; Xu B; Li H; Zou Y
    Acta Oncol; 2009; 48(3):401-10. PubMed ID: 18759148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.
    Guillermet J; Saint-Laurent N; Rochaix P; Cuvillier O; Levade T; Schally AV; Pradayrol L; Buscail L; Susini C; Bousquet C
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):155-60. PubMed ID: 12490654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.
    Cordelier P; Bienvenu C; Lulka H; Marrache F; Bouisson M; Openheim A; Strayer DS; Vaysse N; Pradayrol L; Buscail L
    Cancer Gene Ther; 2007 Jan; 14(1):19-29. PubMed ID: 16990845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas.
    Acunzo J; Thirion S; Roche C; Saveanu A; Gunz G; Germanetti AL; Couderc B; Cohen R; Figarella-Branger D; Dufour H; Brue T; Enjalbert A; Barlier A
    Cancer Res; 2008 Dec; 68(24):10163-70. PubMed ID: 19074883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis.
    Rodrigo-Garzón M; Berraondo P; Ochoa L; Zulueta JJ; González-Aseguinolaza G
    Cancer Gene Ther; 2010 Jan; 17(1):20-7. PubMed ID: 19575045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.